[1]
H.-Y. Chiu, “Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study”, Acta Derm Venereol, vol. 98, no. 9, pp. 829–834, Jun. 2018.